Dendritic cells augment granulocyte-macrophage colonystimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer

Cancer Gene Therapy

Volumn 5, Issue 6, 1998, Pages 380-389

  Miller, Patrice W ^a,b   Sharma, Sherven ^a   Stolina, Marina ^a   Chen, Ken ^a   Zhu, Li ^a   Paul, Ralph W ^c   Dubinett, Steven M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Targeted Genetics Corporation   (United States)

Author keywords

Dendritic cell; Gene therapy; Granulocyte macrophage colony stimulating factor; Lung cancer

Indexed keywords

GAMMA INTERFERON; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THYMIDINE KINASE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CULTURE; DENDRITIC CELL; ENZYMOLOGY; FEMALE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HERPES SIMPLEX VIRUS; IMMUNOLOGY; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; LYMPHOCYTE; METABOLISM; MOUSE; MOUSE MUTANT;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; DENDRITIC CELLS; FEMALE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; LUNG NEOPLASMS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASM TRANSPLANTATION; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032201373     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Johnson BE, Johnson DH. Lung cancer. In: Mauer AM, Ultmann JE, eds. Current Clinical Oncology. New York: Wiley-Liss, Inc.; 1995: xiii-xiv.
2. Tepper R, Mule J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther. 1994;5:153-164.
3. Rosenberg S. Immunotherapy and gene therapy of cancer. Cancer Res. 1991;51:5074-5079.
4. Dubinett SM, Kradin RL. Cytokine immunotherapy of non-small cell lung cancer. Reg Immunol. 1993;5:232-242.
5. Kradin RL, Boyle LA, Preffer FI, et al. Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother. 1987;24:76-85.
6. Sharma S, Wang J, Huang M, et al. Interleukin-7 gene transfer in non-small cell-lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther. 1996;3:302-313.
7. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med. 1990;172:1217-1224.
8. Pardoll DM. Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol. 1995;13:399-415.
9. McBride WH, Thacker JD, Comora S, et al. Genetic modification of a murine fibrosarcoma to produce IL-7 stimulates host cell infiltration and tumor immunity. Cancer Res. 1992;52:3931-3937.
10. Chen S-H, Li Chen XH, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA. 1995;92:2577-2581.
11. Storkus W, Lotze M. Biology of tumor antigens: tumor antigens recognized by immune cells. In: DeVita V, Hellman S, Rosenberg S, eds. Biologic Therapy of Cancer. Philadelphia: J.B. Lippincott Company; 1995:64-77.
12. Boon T, Cerottini J-C, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337-365.
13. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol. 1993:191-212.
14. Yuhas J, Toya R, Wagner E. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma. Cancer Res. 1975;35:242-244.
15. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993;90:3539-3543.
16. Demetri G, Antman K. Granulocyte-macrophage colonystimulating factor (GM-CSF): preclinical and clinical investigations. Semin Oncol. 1992;19:362-385.
17. Griffin J, Spertini O, Ernst T, et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J Immunal. 1990;145:576-584.
18. Gabrilovich D, Ciernik I, Carbone D. Dendritic cells in antitumor immune responses. Cell Immunol. 1996;170: 101-110.
19. Elshami AA, Saavedra A, Zhang H, et al. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 1996;3:85-92.
20. Bevan MJ. Antigen presentation to cytotoxic T lympho-cytes in vivo. J Exp Med. 1995;182:639-641.
21. Watson GA, Lopez DM. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J Immunol. 1995;155:3124-3134.
22. Restifo NP, Esquivel F, Kawakami Y, et al. Identification of human cancers deficient in antigen processing. J Exp Med. 1993;177:265-272.
23. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 1994;264:961-965.
24. Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
25. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693-1702.
26. Lupton SD, Brunton LL, Kalberg VA, Overell RW. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol. 1991;11:3374-3378.
27. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986;6:2895-2902.
28. Parks G, Duke G, Palmenberg A. Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5′ noncoding sequences to the P3 region. J Virol. 1986;60:376-384.
29. Bunnak J, Takigami M, Ito H, Shinozawa T. Gamma irradiation effects on cultured cells: investigated by the MTT method. J Radiat Res. 1994;35:205-212.
30. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD, Jr. Peptide-pulsed dendritic cells induce antigenspecific, CTL-mediated protective tumor immunity. J Exp Med. 1996;183:283-287.
31. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrowderived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med. 1995;1:1297-1302.
32. Dilloo D, Bacon K, Holden W, et al. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med. 1996;2:1090-1095.
33. Levitsky H, Montgomery J, Ahmadzadeh M, et al. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J Immunol. 1996;156:3858-3865.
34. Schwartzentruber D, Solomon D, Rosenberg S, Topalian S. Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother. 1992;12:1-12.
35. Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cells induces tumor-specific cytotoxic T cells in mice. Cancer Gene Ther. 1997;4:91-96.
36. Santodonato L, Ferrantini M, Gabriele L, et al. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-α1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gene Ther. 1996;7:1-10.
37. Pavlovic J, Nawrath M, Tu R, Heinicke T, Moelling K. Anti-tumor immunity is involved in the thymidine kinasemediated killing of tumors induced by activated Kiras(G12V). Gene Ther. 1996;3:635-643.
38. Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 1996;2:1096-1103.
39. Bi W, Kim YG, Feliciano ES, et al. An HSV-tk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther. 1997;4:246-252.
40. Vile RG, Castleden S, Marshall J, Camplejohn R, Upton C, Chong H. Generation of an anti-tumor immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th-1-like profile of intratumoural cytokine expression. Int J Cancer. 1997;71:267-274.
41. Allione A, Consalvo M, Nanni P, et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res. 1994;54:6022-6026.
42. Bukowski RM, Murthy S, McLain D, et al. Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects. J Immunother. 1993;13:267-74.
43. Lee C-T, Wu S, Ciernik F, et al. Genetic immunotherapy of established tumors with adenovirus-murine granulocytemacrophage colony-stimulating factor. Hum Gene Ther. 1997;8:187-193.
44. Grabbe S, Bruvers S, Gallo R, Knisely T, Nazarenos R, Granstein R. Tumor antigen presentation by murine epidermal cells. J Immunol. 1991;146:3656-3661.
45. Qin Z, Noffz G, Mohaupt M, Blankenstein T. IL-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor genemodified tumor cells. J Immunol. 1997:770-776.
46. Ioannides CG, Whiteside TL. T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clinical Immunol Immimopathol. 1993;66:91-106.
47. Huang M, Wang J, Lee P, et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 1995;55:3847-3853.
48. Dubinett S, Huang M, Dhanani S, et al. Down-regulation of murine fibrosarcoma transforming growth factor-β1 expression by interleukin 7. J Natl Cancer Inst. 1995;87: 593-597.
49. Siegfried JM, Owens SE. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line. Cancer Res. 1988;48:4976-4981.
50. Barratt-Boyes S, Watkins S, Finn O. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J Immunol. 1997;158:4543-4547.